Related references
Note: Only part of the references are listed.Reliability of a single-region sample to evaluate tumor immune microenvironment in hepatocellular carcinoma
Ying-Chun Shen et al.
JOURNAL OF HEPATOLOGY (2020)
Heterogeneous immunogenomic features and distinct escape mechanisms in multifocal hepatocellular carcinoma
Liang-qing Dong et al.
JOURNAL OF HEPATOLOGY (2020)
Intratumoral heterogeneity and clonal evolution in liver cancer
Bojan Losic et al.
NATURE COMMUNICATIONS (2020)
Cancer stemness in hepatocellular carcinoma: mechanisms and translational potential
Yu-Man Tsui et al.
BRITISH JOURNAL OF CANCER (2020)
Prospects and challenges of circulating tumor DNA in precision medicine of hepatocellular carcinoma
Jialei Weng et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2020)
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Postoperative circulating tumor cells: An early predictor of extrahepatic metastases in patients with hepatocellular carcinoma undergoing curative surgical resection
Yun-Fan Sun et al.
CANCER CYTOPATHOLOGY (2020)
Hepatocellular Carcinoma Detection by Plasma Methylated DNA: Discovery, Phase I Pilot, and Phase II Clinical Validation
John B. Kisiel et al.
HEPATOLOGY (2019)
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells
Yohan Kim et al.
JOURNAL OF HEPATOLOGY (2019)
Genomic and transcriptional heterogeneity of multifocal hepatocellular carcinoma
L. X. Xu et al.
ANNALS OF ONCOLOGY (2019)
Sirtuin-1/Mitochondrial Ribosomal Protein S5 Axis Enhances the Metabolic Flexibility of Liver Cancer Stem Cells
Zhihao Wei et al.
HEPATOLOGY (2019)
IL-10 derived from M2 macrophage promotes cancer stemness via JAK1/STAT1/NF-κB/Notch1 pathway in non-small cell lung cancer
Li Yang et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Diagnostic Value of Different Phenotype Circulating Tumor Cells in Hepatocellular Carcinoma
Yuan Cheng et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2019)
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
Ying Jiang et al.
NATURE (2019)
Detection of early-stage hepatocellular carcinoma in asymptomatic HBsAg-seropositive individuals by liquid biopsy
Chunfeng Qu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Clinical implications of heterogeneity in PD-L1 immunohistochemical detection in hepatocellular carcinoma: the Blueprint-HCC study
David J. Pinato et al.
BRITISH JOURNAL OF CANCER (2019)
Genomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular Subtypes
Ruidong Xue et al.
CANCER CELL (2019)
Single-Cell Analysis of the Liver Epithelium Reveals Dynamic Heterogeneity and an Essential Role for YAP in Homeostasis and Regeneration
Brian J. Pepe-Mooney et al.
CELL STEM CELL (2019)
c-Met Signaling Is Essential for Mouse Adult Liver Progenitor Cells Expansion After Transforming Growth Factor-β-Induced Epithelial-Mesenchymal Transition and Regulates Cell Phenotypic Switch
Laura Almale et al.
STEM CELLS (2019)
Molecular Profiling of Hepatocellular Carcinoma Using Circulating Cell-Free DNA
Ahmed O. Kaseb et al.
CLINICAL CANCER RESEARCH (2019)
Comprehensive Liquid Profiling of Circulating Tumor DNA and Protein Biomarkers in Long-Term Follow-Up Patients with Hepatocellular Carcinoma
Zhixiong Cai et al.
CLINICAL CANCER RESEARCH (2019)
Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma
Jessica Howell et al.
EUROPEAN JOURNAL OF CANCER (2019)
Integrated multiomic analysis reveals comprehensive tumour heterogeneity and novel immunophenotypic classification in hepatocellular carcinomas
Qi Zhang et al.
GUT (2019)
Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma
Jiabin Cai et al.
GUT (2019)
Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
Qianwei Ye et al.
MOLECULAR CANCER (2019)
A human liver cell atlas reveals heterogeneity and epithelial progenitors
Nadim Aizarani et al.
NATURE (2019)
Circulating Tumor DNA and Hepatocellular Carcinoma
Ju Dong Yang et al.
SEMINARS IN LIVER DISEASE (2019)
β-Catenin Activation Promotes Immune Escape and Resistance to Anti-PD-1 Therapy in Hepatocellular Carcinoma
Marina Ruiz de Galarreta et al.
CANCER DISCOVERY (2019)
Single-cell transcriptomics reveals the landscape of intra-tumoral heterogeneity and sternness-related subpopulations in liver cancer
Daniel Wai-Hung Ho et al.
CANCER LETTERS (2019)
Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas
Xiaofan Ding et al.
GASTROENTEROLOGY (2019)
Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial
Marianna Alunni-Fabbroni et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers
Aparna R. Parikh et al.
NATURE MEDICINE (2019)
A global view of hepatocellular carcinoma: trends, risk, prevention and management
Ju Dong Yang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Tumor Cell Biodiversity Drives Microenvironmental Reprogramming in Liver Cancer
Lichun Ma et al.
CANCER CELL (2019)
Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma
Qiming Zhang et al.
CELL (2019)
Circulating tumor cells are associated with poor outcomes in early-stage hepatocellular carcinoma: a prospective study
Yeonjung Ha et al.
HEPATOLOGY INTERNATIONAL (2019)
Genomic and transcriptional Profiling of tumor infiltrated CD8+ T cells revealed functional heterogeneity of antitumor immunity in hepatocellular carcinoma
Zhenli Li et al.
ONCOIMMUNOLOGY (2019)
Comprehensive molecular and immunological characterization of hepatocellular carcinoma
Shu Shimada et al.
EBIOMEDICINE (2019)
Characterization of heterogeneous redox responses in hepatocellular carcinoma patients using network analysis
Rui Benfeitas et al.
EBIOMEDICINE (2019)
New Labyrinth Microfluidic Device Detects Circulating Tumor Cells Expressing Cancer Stem Cell Marker and Circulating Tumor Microemboli in Hepatocellular Carcinoma
Shanshan Wan et al.
SCIENTIFIC REPORTS (2019)
Maintenance of Primary Hepatocyte Functions In Vitro by Inhibiting Mechanical Tension-Induced YAP Activation
Pingxin Sun et al.
CELL REPORTS (2019)
Feasibility of circulating tumor DNA testing in hepatocellular carcinoma
Kabir Mody et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2019)
Correlation Between Postoperative Early Recurrence of Hepatocellular Carcinoma and Mesenchymal Circulating Tumor Cells in Peripheral Blood
Zhong Wang et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2018)
Tumour heterogeneity and resistance to cancer therapies
Ibiayi Dagogo-Jack et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Acquisition of Cholangiocarcinoma Traits during Advanced Hepatocellular Carcinoma Development in Mice
Liyuan Li et al.
AMERICAN JOURNAL OF PATHOLOGY (2018)
Genetic profiling using plasma-derived cell-free DNA in therapy-naive hepatocellular carcinoma patients: a pilot study
C. K. Y. Ng et al.
ANNALS OF ONCOLOGY (2018)
Quantified postsurgical small cell size CFCs and EpCAM(+) circulating tumor stem cells with cytogenetic abnormalities in hepatocellular carcinoma patients determine cancer relapse
Liang Wang et al.
CANCER LETTERS (2018)
Kras and Tp53 Mutations Cause Cholangiocyte- and Hepatocyte-Derived Cholangiocarcinoma
Margaret A. Hill et al.
CANCER RESEARCH (2018)
Circulating Tumor Cells Undergoing EMT Provide a Metric for Diagnosis and Prognosis of Patients with Hepatocellular Carcinoma
Lu-Nan Qi et al.
CANCER RESEARCH (2018)
Metabolic reprogramming enables hepatocarcinoma cells to efficiently adapt and survive to a nutrient-restricted microenvironment
Shamir Cassim et al.
CELL CYCLE (2018)
Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with RAS-Mutated Hepatocellular Carcinoma
Ho Yeong Lim et al.
CLINICAL CANCER RESEARCH (2018)
Landscape of immune microenvironment in hepatocellular carcinoma and its additional impact on histological and molecular classification
Yutaka Kurebayashi et al.
HEPATOLOGY (2018)
Single-cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinoma
Hongping Zheng et al.
HEPATOLOGY (2018)
Macrotrabecular-massive hepatocellular carcinoma: A distinctive histological subtype with clinical relevance
Marianne Ziol et al.
HEPATOLOGY (2018)
Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine
Naoto Fujiwara et al.
JOURNAL OF HEPATOLOGY (2018)
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2018)
A novel multimarker assay for the phenotypic profiling of circulating tumor cells in hepatocellular carcinoma
Colin M. Court et al.
LIVER TRANSPLANTATION (2018)
Analysis of Tissue and Circulating Tumor DNA by Next-Generation Sequencing of Hepatocellular Carcinoma: Implications for Targeted Therapeutics
Sadakatsu Ikeda et al.
MOLECULAR CANCER THERAPEUTICS (2018)
A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma
Ismail Labgaa et al.
ONCOGENE (2018)
Next-Generation Sequencing of Circulating Tumor DNA Reveals Frequent Alterations in Advanced Hepatocellular Carcinoma
Sadakatsu Ikeda et al.
ONCOLOGIST (2018)
Plasma mSEPT9: A Novel Circulating Cell-free DNA-Based Epigenetic Biomarker to Diagnose Hepatocellular Carcinoma
Abderrahim Oussalah et al.
EBIOMEDICINE (2018)
Effect of surgical liver resection on circulating tumor cells in patients with hepatocellular carcinoma
Jing-jing Yu et al.
BMC CANCER (2018)
Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis
Isabel Fabregat et al.
FRONTIERS IN ONCOLOGY (2018)
Metabolic network-based stratification of hepatocellular carcinoma reveals three distinct tumor subtypes
Gholamreza Bidkhori et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Preferred end coordinates and somatic variants as signatures of circulating tumor DNA associated with hepatocellular carcinoma
Peiyong Jiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Detection of promoter methylation status of suppressor of cytokine signaling 3 (SOCS3) in tissue and plasma from Chinese patients with different hepatic diseases
Ling Wei et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2018)
Telomerase Reverse Transcriptase Mutations in Plasma DNA in Patients With Hepatocellular Carcinoma or Cirrhosis: Prevalence and Risk Factors
Jingjing Jiao et al.
HEPATOLOGY COMMUNICATIONS (2018)
Circulating Tumor Cells from Different Vascular Sites Exhibit Spatial Heterogeneity in Epithelial and Mesenchymal Composition and Distinct Clinical Significance in Hepatocellular Carcinoma
Yun-Fan Sun et al.
CLINICAL CANCER RESEARCH (2018)
TSC1/2 mutations define a molecular subset of HCC with aggressive behaviour and treatment implication
Daniel W. H. Ho et al.
GUT (2017)
Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features
Daniela Sia et al.
GASTROENTEROLOGY (2017)
Human Hepatocellular Carcinomas With a Periportal Phenotype Have the Lowest Potential for Early Recurrence After Curative Resection
Romain Desert et al.
HEPATOLOGY (2017)
Circulating tumor DNA profiling reveals clonal evolution and real-time disease progression in advanced hepatocellular carcinoma
Zhi-Xiong Cai et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Whole genome sequencing discriminates hepatocellular carcinoma with intrahepatic metastasis from multi-centric tumors
Mayuko Furuta et al.
JOURNAL OF HEPATOLOGY (2017)
Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification
Julien Calderaro et al.
JOURNAL OF HEPATOLOGY (2017)
Circumventing intratumoral heterogeneity to identify potential therapeutic targets in hepatocellular carcinoma
Ao Huang et al.
JOURNAL OF HEPATOLOGY (2017)
Trunk mutational events present minimal intra- and inter-tumoral heterogeneity in hepatocellular carcinoma
Sara Torrecilla et al.
JOURNAL OF HEPATOLOGY (2017)
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
Anthony B. El-Khoueiry et al.
LANCET (2017)
Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma
Rui-hua Xu et al.
NATURE MATERIALS (2017)
Targeted deep sequencing of plasma circulating cell-free DNA reveals Vimentin and Fibulin 1 as potential epigenetic biomarkers for hepatocellular carcinoma
Reetta Holmila et al.
PLOS ONE (2017)
Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses
Valerie Chew et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Hypomethylated Ubiquitin-Conjugating Enzyme2 Q1 (UBE2Q1) Gene Promoter in the Serum Is a Promising Biomarker for Hepatitis B Virus-Associated Hepatocellular Carcinoma
Na Hu et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Intratumoral heterogeneity of intrahepatic cholangiocarcinoma
Dirk Walter et al.
ONCOTARGET (2017)
Hepatocellular Carcinomas Originate Predominantly from Hepatocytes and Benign Lesions from Hepatic Progenitor Cells
Krishna S. Tummala et al.
CELL REPORTS (2017)
Epithelial-mesenchymal transition phenotypes of circulating tumor cells correlate with the clinical stages and cancer metastasis in hepatocellular carcinoma patients
Jing Chen et al.
CANCER BIOMARKERS (2017)
Plasma DNA methylation marker and hepatocellular carcinoma risk prediction model for the general population
Hui-Chen Wu et al.
CARCINOGENESIS (2017)
Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing
Chunhong Zheng et al.
CELL (2017)
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma
Adrian Ally et al.
CELL (2017)
Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
Jordi Bruix et al.
GASTROENTEROLOGY (2016)
Variable Intra-Tumor Genomic Heterogeneity of Multiple Lesions in Patients With Hepatocellular Carcinoma
Ruidong Xue et al.
GASTROENTEROLOGY (2016)
The plastic cellular states of liver cells: Are EpCAM and Lgr5 fit for purpose?
Meritxell Huch et al.
HEPATOLOGY (2016)
Regulation of a TGF-β1-CD147 self-sustaining network in the differentiation plasticity of hepatocellular carcinoma cells
J. Wu et al.
ONCOGENE (2016)
Noninvasive detection of tumor-associated mutations from circulating cell-free DNA in hepatocellular carcinoma patients by targeted deep sequencing
Wenjun Liao et al.
ONCOTARGET (2016)
Detecting Circulating Tumor DNA in Hepatocellular Carcinoma Patients Using Droplet Digital PCR Is Feasible and Reflects Intratumoral Heterogeneity
Ao Huang et al.
JOURNAL OF CANCER (2016)
Tumor Heterogeneity in Hepatocellular Carcinoma: Facing the Challenges
Li-Chun Lu et al.
LIVER CANCER (2016)
Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Circulating tumor cell detection in hepatocellular carcinoma based on karyoplasmic ratios using imaging flow cytometry
Zixin Liu et al.
SCIENTIFIC REPORTS (2016)
Intratumor Heterogeneity in Hepatocellular Carcinoma
Juliane Friemel et al.
CLINICAL CANCER RESEARCH (2015)
Functional and genetic deconstruction of the cellular origin in liver cancer
Jens U. Marquardt et al.
NATURE REVIEWS CANCER (2015)
Blockade of CD47-Mediated Cathepsin S/Protease-Activated Receptor 2 Signaling Provides a Therapeutic Target for Hepatocellular Carcinoma
Terence Kin-Wah Lee et al.
HEPATOLOGY (2014)
Identification of Liver Cancer Progenitors Whose Malignant Progression Depends on Autocrine IL-6 Signaling
Guobin He et al.
CELL (2013)
Cancer stem cells in the development of liver cancer
Taro Yamashita et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
The causes and consequences of genetic heterogeneity in cancer evolution
Rebecca A. Burrell et al.
NATURE (2013)
TP53 R249S mutation, genetic variations in HBX and risk of hepatocellular carcinoma in The Gambia
Doriane A. Gouas et al.
CARCINOGENESIS (2012)
Wnt-Pathway Activation in Two Molecular Classes of Hepatocellular Carcinoma and Experimental Modulation by Sorafenib
Anja Lachenmayer et al.
CLINICAL CANCER RESEARCH (2012)
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma
Cecile Guichard et al.
NATURE GENETICS (2012)
CD24+ Liver Tumor-Initiating Cells Drive Self-Renewal and Tumor Initiation through STAT3-Mediated NANOG Regulation
Terence Kin Wah Lee et al.
CELL STEM CELL (2011)
Concordance of DNA methylation pattern in plasma and tumor DNA of Egyptian hepatocellular carcinoma patients
Priyanka Iyer et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2010)
CD13 is a therapeutic target in human liver cancer stem cells
Naotsugu Haraguchi et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Molecular Classification and Novel Targets in Hepatocellular Carcinoma: Recent Advancements
Yujin Hoshida et al.
SEMINARS IN LIVER DISEASE (2010)
Integrative Transcriptome Analysis Reveals Common Molecular Subclasses of Human Hepatocellular Carcinoma
Yujin Hoshida et al.
CANCER RESEARCH (2009)
EpCAM-Positive Hepatocellular Carcinoma Cells Are Tumor-Initiating Cells With Stem/Progenitor Cell Features
Taro Yamashita et al.
GASTROENTEROLOGY (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Significance of CD90+ cancer stem cells in human liver cancer
Zhen Fan Yang et al.
CANCER CELL (2008)
Focal gains of VEGFA and molecular classification of hepatocellular carcinoma
Derek Y. Chiang et al.
CANCER RESEARCH (2008)
Transforming growth factor-β and hepatocyte transdifferentiation in liver fibrogenesis
Nadja M. Meindl-Beinker et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Identification and characterization of tumorigenic liver cancer stem/progenitor cells
Stephanie Ma et al.
GASTROENTEROLOGY (2007)
Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets
Sandrine Boyault et al.
HEPATOLOGY (2007)
Early and late recurrence after liver resection for hepatocellular carcinoma - Prognostic and therapeutic implications
N Portolani et al.
ANNALS OF SURGERY (2006)
Circulating tumor cells in patients with breast cancer dormancy
SD Meng et al.
CLINICAL CANCER RESEARCH (2004)
Determination of the molecular relationship between multiple tumour nodules in hepatocellular carcinoma differentiates multicentric origin from intrahepatic metastasis
IOL Ng et al.
JOURNAL OF PATHOLOGY (2003)
Share Paper
